25 XP   0   0   10

Dongwha Pharm.Co.Ltd
Buy, Hold or Sell?

Let's analyse Dongwha Pharm.Co.Ltd together

PenkeI guess you are interested in Dongwha Pharm.Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dongwha Pharm.Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dongwha Pharm.Co.Ltd

I send you an email if I find something interesting about Dongwha Pharm.Co.Ltd.

Quick analysis of Dongwha Pharm.Co.Ltd (30 sec.)










What can you expect buying and holding a share of Dongwha Pharm.Co.Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.13
When do you have the money?
1 year
How often do you get paid?
71.4%

What is your share worth?

Current worth
₩14,685.69
Expected worth in 1 year
₩15,709.69
How sure are you?
89.3%

+ What do you gain per year?

Total Gains per Share
₩1,203.75
Return On Investment
14.2%

For what price can you sell your share?

Current Price per Share
₩8,470.00
Expected price per share
₩8,070 - ₩9,300
How sure are you?
50%

1. Valuation of Dongwha Pharm.Co.Ltd (5 min.)




Live pricePrice per Share (EOD)

₩8,470.00

Intrinsic Value Per Share

₩-28,637.29 - ₩-34,628.37

Total Value Per Share

₩-13,951.61 - ₩-19,942.68

2. Growth of Dongwha Pharm.Co.Ltd (5 min.)




Is Dongwha Pharm.Co.Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$284.9m$258.3m$19.8m7.1%

How much money is Dongwha Pharm.Co.Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4.8m$3.5m$1.2m25.7%
Net Profit Margin7.4%6.0%--

How much money comes from the company's main activities?

3. Financial Health of Dongwha Pharm.Co.Ltd (5 min.)




What can you expect buying and holding a share of Dongwha Pharm.Co.Ltd? (5 min.)

Welcome investor! Dongwha Pharm.Co.Ltd's management wants to use your money to grow the business. In return you get a share of Dongwha Pharm.Co.Ltd.

What can you expect buying and holding a share of Dongwha Pharm.Co.Ltd?

First you should know what it really means to hold a share of Dongwha Pharm.Co.Ltd. And how you can make/lose money.

Speculation

The Price per Share of Dongwha Pharm.Co.Ltd is ₩8,470. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dongwha Pharm.Co.Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dongwha Pharm.Co.Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩14,685.69. Based on the TTM, the Book Value Change Per Share is ₩256.00 per quarter. Based on the YOY, the Book Value Change Per Share is ₩167.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩44.94 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dongwha Pharm.Co.Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.040.0%0.170.0%0.130.0%0.130.0%0.160.0%
Usd Book Value Change Per Share0.160.0%0.180.0%0.120.0%0.130.0%0.160.0%
Usd Dividend Per Share0.000.0%0.030.0%0.030.0%0.060.0%0.060.0%
Usd Total Gains Per Share0.160.0%0.210.0%0.150.0%0.200.0%0.220.0%
Usd Price Per Share7.19-6.78-7.15-8.46-7.98-
Price to Earnings Ratio48.42-18.52-14.75-34.94-35.53-
Price-to-Total Gains Ratio45.03-36.08-50.09--156.90--70.42-
Price to Book Ratio0.70-0.68-0.77-0.97-0.97-
Price-to-Total Gains Ratio45.03-36.08-50.09--156.90--70.42-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.929
Number of shares168
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.06
Usd Book Value Change Per Share0.180.13
Usd Total Gains Per Share0.210.20
Gains per Quarter (168 shares)35.3933.52
Gains per Year (168 shares)141.56134.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1211201324490124
24224127487181258
363361416131271392
485482558175362526
5106602700218452660
6127723842262543794
7148843984305633928
816996311263497231062
9190108412683938141196
10211120414104369041330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%27.01.00.096.4%28.02.00.093.3%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%23.05.00.082.1%24.06.00.080.0%
Dividend per Share1.00.03.025.0%6.00.06.050.0%12.00.08.060.0%20.00.08.071.4%22.00.08.073.3%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%17.03.00.085.0%25.03.00.089.3%27.03.00.090.0%

Fundamentals of Dongwha Pharm.Co.Ltd

About Dongwha Pharm.Co.Ltd

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-04-13 15:21:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Dongwha Pharm.Co.Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dongwha Pharm.Co.Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Dongwha Pharm.Co.Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 1.7% means that ₩0.02 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dongwha Pharm.Co.Ltd:

  • The MRQ is 1.7%. The company is making a profit. +1
  • The TTM is 7.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.7%TTM7.4%-5.6%
TTM7.4%YOY6.0%+1.4%
TTM7.4%5Y6.5%+0.8%
5Y6.5%10Y8.7%-2.1%
1.1.2. Return on Assets

Shows how efficient Dongwha Pharm.Co.Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dongwha Pharm.Co.Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.3% Return on Assets means that Dongwha Pharm.Co.Ltd generated ₩0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dongwha Pharm.Co.Ltd:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.3%TTM1.4%-1.2%
TTM1.4%YOY1.1%+0.3%
TTM1.4%5Y1.2%+0.2%
5Y1.2%10Y1.6%-0.4%
1.1.3. Return on Equity

Shows how efficient Dongwha Pharm.Co.Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dongwha Pharm.Co.Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.4% Return on Equity means Dongwha Pharm.Co.Ltd generated ₩0.00 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dongwha Pharm.Co.Ltd:

  • The MRQ is 0.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM1.8%-1.4%
TTM1.8%YOY1.4%+0.4%
TTM1.8%5Y1.5%+0.3%
5Y1.5%10Y2.0%-0.5%

1.2. Operating Efficiency of Dongwha Pharm.Co.Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dongwha Pharm.Co.Ltd is operating .

  • Measures how much profit Dongwha Pharm.Co.Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dongwha Pharm.Co.Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dongwha Pharm.Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY8.8%-8.8%
TTM-5Y7.0%-7.0%
5Y7.0%10Y6.0%+1.0%
1.2.2. Operating Ratio

Measures how efficient Dongwha Pharm.Co.Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.47 means that the operating costs are ₩1.47 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Dongwha Pharm.Co.Ltd:

  • The MRQ is 1.466. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.424. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.466TTM1.424+0.042
TTM1.424YOY1.272+0.151
TTM1.4245Y1.396+0.028
5Y1.39610Y1.444-0.048

1.3. Liquidity of Dongwha Pharm.Co.Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dongwha Pharm.Co.Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.24 means the company has ₩2.24 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Dongwha Pharm.Co.Ltd:

  • The MRQ is 2.240. The company is able to pay all its short-term debts. +1
  • The TTM is 2.774. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.240TTM2.774-0.534
TTM2.774YOY3.087-0.313
TTM2.7745Y3.394-0.620
5Y3.39410Y3.369+0.025
1.3.2. Quick Ratio

Measures if Dongwha Pharm.Co.Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dongwha Pharm.Co.Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.77 means the company can pay off ₩0.77 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dongwha Pharm.Co.Ltd:

  • The MRQ is 0.765. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.076. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.765TTM1.076-0.311
TTM1.076YOY1.765-0.689
TTM1.0765Y1.836-0.760
5Y1.83610Y1.894-0.058

1.4. Solvency of Dongwha Pharm.Co.Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dongwha Pharm.Co.Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dongwha Pharm.Co.Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.28 means that Dongwha Pharm.Co.Ltd assets are financed with 28.0% credit (debt) and the remaining percentage (100% - 28.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dongwha Pharm.Co.Ltd:

  • The MRQ is 0.280. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.208. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.280TTM0.208+0.072
TTM0.208YOY0.204+0.004
TTM0.2085Y0.208+0.000
5Y0.20810Y0.209-0.002
1.4.2. Debt to Equity Ratio

Measures if Dongwha Pharm.Co.Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dongwha Pharm.Co.Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 42.5% means that company has ₩0.42 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dongwha Pharm.Co.Ltd:

  • The MRQ is 0.425. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.282. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.425TTM0.282+0.143
TTM0.282YOY0.266+0.015
TTM0.2825Y0.271+0.011
5Y0.27110Y0.2710.000

2. Market Valuation of Dongwha Pharm.Co.Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Dongwha Pharm.Co.Ltd generates.

  • Above 15 is considered overpriced but always compare Dongwha Pharm.Co.Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 48.42 means the investor is paying ₩48.42 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dongwha Pharm.Co.Ltd:

  • The EOD is 39.936. Based on the earnings, the company is overpriced. -1
  • The MRQ is 48.423. Based on the earnings, the company is overpriced. -1
  • The TTM is 18.518. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD39.936MRQ48.423-8.487
MRQ48.423TTM18.518+29.905
TTM18.518YOY14.747+3.770
TTM18.5185Y34.939-16.421
5Y34.93910Y35.535-0.596
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dongwha Pharm.Co.Ltd:

  • The EOD is -4.404. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.340. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 13.368. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-4.404MRQ-5.340+0.936
MRQ-5.340TTM13.368-18.708
TTM13.368YOY-23.617+36.985
TTM13.3685Y-2.827+16.195
5Y-2.82710Y-2.019-0.808
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dongwha Pharm.Co.Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.70 means the investor is paying ₩0.70 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Dongwha Pharm.Co.Ltd:

  • The EOD is 0.577. Based on the equity, the company is cheap. +2
  • The MRQ is 0.699. Based on the equity, the company is cheap. +2
  • The TTM is 0.676. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.577MRQ0.699-0.123
MRQ0.699TTM0.676+0.024
TTM0.676YOY0.770-0.094
TTM0.6765Y0.973-0.298
5Y0.97310Y0.973+0.001
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dongwha Pharm.Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--228.053256.000-11%167.221+36%192.248+19%233.664-2%
Book Value Per Share--14685.68614334.934+2%13314.111+10%12523.327+17%11796.490+24%
Current Ratio--2.2402.774-19%3.087-27%3.394-34%3.369-34%
Debt To Asset Ratio--0.2800.208+34%0.204+37%0.208+35%0.209+34%
Debt To Equity Ratio--0.4250.282+51%0.266+59%0.271+57%0.271+57%
Dividend Per Share---44.937-100%44.937-100%92.746-100%84.042-100%
Eps--53.023247.478-79%183.847-71%186.887-72%226.977-77%
Free Cash Flow Per Share---480.76225.444-1989%82.341-684%102.192-570%102.192-570%
Free Cash Flow To Equity Per Share---480.76225.444-1989%-26.010-95%42.993-1218%42.993-1218%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---34628.368--------
Intrinsic Value_10Y_min---28637.292--------
Intrinsic Value_1Y_max---263.969--------
Intrinsic Value_1Y_min---257.396--------
Intrinsic Value_3Y_max---3236.491--------
Intrinsic Value_3Y_min---3040.495--------
Intrinsic Value_5Y_max---9154.778--------
Intrinsic Value_5Y_min---8286.932--------
Market Cap234770613000.000-21%284662833000.000268655745750.000+6%283138348500.000+1%334804514100.000-15%316214204250.000-10%
Net Profit Margin--0.0170.074-76%0.060-71%0.065-73%0.087-80%
Operating Margin----0%0.088-100%0.070-100%0.060-100%
Operating Ratio--1.4661.424+3%1.272+15%1.396+5%1.444+1%
Pb Ratio0.577-21%0.6990.676+4%0.770-9%0.973-28%0.973-28%
Pe Ratio39.936-21%48.42318.518+161%14.747+228%34.939+39%35.535+36%
Price Per Share8470.000-21%10270.0009692.500+6%10215.000+1%12079.000-15%11406.071-10%
Price To Free Cash Flow Ratio-4.404+18%-5.34013.368-140%-23.617+342%-2.827-47%-2.019-62%
Price To Total Gains Ratio37.141-21%45.03336.081+25%50.095-10%-156.900+448%-70.418+256%
Quick Ratio--0.7651.076-29%1.765-57%1.836-58%1.894-60%
Return On Assets--0.0030.014-82%0.011-76%0.012-78%0.016-83%
Return On Equity--0.0040.018-78%0.014-73%0.015-74%0.020-80%
Total Gains Per Share--228.053300.937-24%212.158+7%284.994-20%317.706-28%
Usd Book Value--284939456.025278133978.339+2%258327447.644+10%242984228.002+17%228930038.792+24%
Usd Book Value Change Per Share--0.1600.179-11%0.117+36%0.135+19%0.164-2%
Usd Book Value Per Share--10.28010.034+2%9.320+10%8.766+17%8.258+24%
Usd Dividend Per Share---0.031-100%0.031-100%0.065-100%0.059-100%
Usd Eps--0.0370.173-79%0.129-71%0.131-72%0.159-77%
Usd Free Cash Flow---9328000.927493679.697-1989%1597623.458-684%1586226.875-688%1133019.197-923%
Usd Free Cash Flow Per Share---0.3370.018-1989%0.058-684%0.072-570%0.072-570%
Usd Free Cash Flow To Equity Per Share---0.3370.018-1989%-0.018-95%0.030-1218%0.030-1218%
Usd Market Cap164339429.100-21%199263983.100188059022.025+6%198196843.950+1%234363159.870-15%221349942.975-10%
Usd Price Per Share5.929-21%7.1896.785+6%7.151+1%8.455-15%7.984-10%
Usd Profit--1028774.8244801700.708-79%3567105.399-71%3626072.535-72%4407571.337-77%
Usd Revenue--58968688.06563193998.350-7%59574607.356-1%55082244.414+7%53056021.496+11%
Usd Total Gains Per Share--0.1600.211-24%0.149+7%0.199-20%0.222-28%
 EOD+3 -5MRQTTM+8 -26YOY+11 -245Y+10 -2510Y+8 -27

3.2. Fundamental Score

Let's check the fundamental score of Dongwha Pharm.Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1539.936
Price to Book Ratio (EOD)Between0-10.577
Net Profit Margin (MRQ)Greater than00.017
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.765
Current Ratio (MRQ)Greater than12.240
Debt to Asset Ratio (MRQ)Less than10.280
Debt to Equity Ratio (MRQ)Less than10.425
Return on Equity (MRQ)Greater than0.150.004
Return on Assets (MRQ)Greater than0.050.003
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Dongwha Pharm.Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.362
Ma 20Greater thanMa 509,058.000
Ma 50Greater thanMa 1009,439.000
Ma 100Greater thanMa 2009,683.300
OpenGreater thanClose8,570.000
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  10011-1000
Operating Income  3,349,2028,833,35012,182,552-6,717,8505,464,702-2,769,8542,694,848-4,261,071-1,566,222



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets564,972,409
Total Liabilities157,916,043
Total Stockholder Equity371,779,503
 As reported
Total Liabilities 157,916,043
Total Stockholder Equity+ 371,779,503
Total Assets = 564,972,409

Assets

Total Assets564,972,409
Total Current Assets237,700,038
Long-term Assets327,272,370
Total Current Assets
Cash And Cash Equivalents 72,317,115
Short-term Investments 16,513,065
Net Receivables 64,716,395
Inventory 70,697,184
Other Current Assets 1,505,527
Total Current Assets  (as reported)237,700,038
Total Current Assets  (calculated)225,749,286
+/- 11,950,752
Long-term Assets
Property Plant Equipment 188,330,487
Goodwill 20,483,277
Intangible Assets 35,994,543
Long-term Assets  (as reported)327,272,370
Long-term Assets  (calculated)244,808,307
+/- 82,464,063

Liabilities & Shareholders' Equity

Total Current Liabilities106,133,855
Long-term Liabilities51,782,188
Total Stockholder Equity371,779,503
Total Current Liabilities
Short Long Term Debt 14,669,995
Accounts payable 31,412,266
Other Current Liabilities 7,425,875
Total Current Liabilities  (as reported)106,133,855
Total Current Liabilities  (calculated)53,508,137
+/- 52,625,718
Long-term Liabilities
Long term Debt 16,127,680
Capital Lease Obligations Min Short Term Debt16,303,363
Long-term Liabilities Other 259,180
Long-term Liabilities  (as reported)51,782,188
Long-term Liabilities  (calculated)32,690,223
+/- 19,091,965
Total Stockholder Equity
Retained Earnings 329,867,741
Total Stockholder Equity (as reported)371,779,503
Total Stockholder Equity (calculated)329,867,741
+/- 41,911,762
Other
Capital Stock27,931,470
Common Stock Shares Outstanding 27,679
Net Invested Capital 402,577,178
Net Working Capital 131,566,184
Property Plant and Equipment Gross 352,943,617



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312013-09-302013-06-30
> Total Assets 
329,073,408
320,631,080
324,604,537
322,490,785
332,518,275
338,913,042
367,225,133
380,677,273
374,926,767
372,532,532
372,270,805
376,070,538
374,778,099
376,028,553
376,185,904
388,290,452
424,561,542
433,807,800
437,269,332
447,079,559
447,872,641
447,804,487
459,969,628
463,911,710
468,461,635
461,136,459
476,990,264
481,755,693
490,151,115
564,972,409
564,972,409490,151,115481,755,693476,990,264461,136,459468,461,635463,911,710459,969,628447,804,487447,872,641447,079,559437,269,332433,807,800424,561,542388,290,452376,185,904376,028,553374,778,099376,070,538372,270,805372,532,532374,926,767380,677,273367,225,133338,913,042332,518,275322,490,785324,604,537320,631,080329,073,408
   > Total Current Assets 
129,973,754
122,182,387
151,491,848
151,943,258
162,256,931
168,967,531
234,500,030
249,506,716
240,910,329
237,352,727
223,482,122
226,736,065
225,784,290
235,456,988
237,916,006
245,802,296
245,994,161
222,743,490
226,781,448
227,363,315
217,964,620
220,198,640
228,741,479
225,738,201
232,053,732
227,527,471
235,656,852
231,666,299
234,588,872
237,700,038
237,700,038234,588,872231,666,299235,656,852227,527,471232,053,732225,738,201228,741,479220,198,640217,964,620227,363,315226,781,448222,743,490245,994,161245,802,296237,916,006235,456,988225,784,290226,736,065223,482,122237,352,727240,910,329249,506,716234,500,030168,967,531162,256,931151,943,258151,491,848122,182,387129,973,754
       Cash And Cash Equivalents 
29,721,767
27,610,483
35,730,377
39,920,511
41,294,356
38,837,887
31,588,170
35,564,400
35,886,865
33,756,379
34,188,972
29,686,674
40,201,256
37,779,183
75,733,693
111,481,830
72,397,341
58,596,431
58,906,163
38,931,149
40,791,572
60,479,643
74,985,003
48,510,402
48,320,232
34,347,104
52,953,172
81,003,949
94,663,758
72,317,115
72,317,11594,663,75881,003,94952,953,17234,347,10448,320,23248,510,40274,985,00360,479,64340,791,57238,931,14958,906,16358,596,43172,397,341111,481,83075,733,69337,779,18340,201,25629,686,67434,188,97233,756,37935,886,86535,564,40031,588,17038,837,88741,294,35639,920,51135,730,37727,610,48329,721,767
       Short-term Investments 
3,020,000
3,020,000
31,020,000
26,020,000
26,201,746
26,020,000
95,020,000
101,320,000
72,220,000
62,220,000
63,044,921
66,053,765
55,927,451
82,242,764
62,300,000
37,053,977
63,815,768
61,734,412
61,400,000
78,997,597
70,607,120
61,030,000
47,635,000
65,952,500
69,982,500
73,347,411
53,137,525
20,854,761
13,738,550
16,513,065
16,513,06513,738,55020,854,76153,137,52573,347,41169,982,50065,952,50047,635,00061,030,00070,607,12078,997,59761,400,00061,734,41263,815,76837,053,97762,300,00082,242,76455,927,45166,053,76563,044,92162,220,00072,220,000101,320,00095,020,00026,020,00026,201,74626,020,00031,020,0003,020,0003,020,000
       Net Receivables 
62,285,937
57,518,603
57,827,135
57,346,025
61,685,386
66,196,611
66,863,782
72,971,717
81,906,975
85,447,076
74,470,621
72,305,801
70,524,571
80,151,143
66,046,854
62,415,082
69,504,106
61,751,717
64,911,627
64,580,254
63,420,346
61,093,479
68,616,398
65,177,412
64,710,638
66,795,270
67,384,001
64,572,652
61,902,382
64,716,395
64,716,39561,902,38264,572,65267,384,00166,795,27064,710,63865,177,41268,616,39861,093,47963,420,34664,580,25464,911,62761,751,71769,504,10662,415,08266,046,85480,151,14370,524,57172,305,80174,470,62185,447,07681,906,97572,971,71766,863,78266,196,61161,685,38657,346,02557,827,13557,518,60362,285,937
       Inventory 
34,439,524
33,475,558
26,577,327
28,169,723
32,414,644
37,336,942
36,606,243
35,954,341
41,968,123
42,028,339
44,361,627
49,479,658
49,992,544
33,430,792
32,637,443
33,618,045
38,957,552
39,504,166
40,448,169
43,109,088
41,963,854
36,243,977
35,668,155
44,055,715
47,067,810
46,783,642
49,386,244
54,927,490
54,743,104
70,697,184
70,697,18454,743,10454,927,49049,386,24446,783,64247,067,81044,055,71535,668,15536,243,97741,963,85443,109,08840,448,16939,504,16638,957,55233,618,04532,637,44333,430,79249,992,54449,479,65844,361,62742,028,33941,968,12335,954,34136,606,24337,336,94232,414,64428,169,72326,577,32733,475,55834,439,524
       Other Current Assets 
506,525
557,743
166,748
212,832
324,057
286,516
1,115,191
342,491
490,868
426,740
237,929
261,660
302,618
964,429
433,452
593,888
918,129
863,851
598,726
1,111,055
700,363
948,429
1,253,960
1,337,994
1,367,668
5,410,667
474,038
465,439
614,800
1,505,527
1,505,527614,800465,439474,0385,410,6671,367,6681,337,9941,253,960948,429700,3631,111,055598,726863,851918,129593,888433,452964,429302,618261,660237,929426,740490,868342,4911,115,191286,516324,057212,832166,748557,743506,525
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
148,788,683
149,334,473
148,993,809
140,571,565
138,269,898
142,488,155
178,567,380
211,064,310
210,487,884
219,716,244
229,908,021
227,605,847
231,228,149
238,173,509
236,407,903
233,608,988
241,333,411
250,089,394
255,562,244
327,272,370
327,272,370255,562,244250,089,394241,333,411233,608,988236,407,903238,173,509231,228,149227,605,847229,908,021219,716,244210,487,884211,064,310178,567,380142,488,155138,269,898140,571,565148,993,809149,334,473148,788,6830000000000
       Property Plant Equipment 
179,891,387
174,411,091
142,170,913
139,753,470
138,412,146
136,136,747
103,746,341
102,134,098
100,054,310
98,001,113
95,343,499
97,129,845
96,741,452
99,214,800
97,708,625
96,974,376
107,534,526
130,950,770
130,254,402
133,989,123
143,601,341
142,850,525
144,311,168
144,174,234
149,463,276
151,152,680
155,061,715
161,677,296
163,195,566
188,330,487
188,330,487163,195,566161,677,296155,061,715151,152,680149,463,276144,174,234144,311,168142,850,525143,601,341133,989,123130,254,402130,950,770107,534,52696,974,37697,708,62599,214,80096,741,45297,129,84595,343,49998,001,113100,054,310102,134,098103,746,341136,136,747138,412,146139,753,470142,170,913174,411,091179,891,387
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,956,289
4,555,792
4,555,792
4,555,792
4,555,792
4,555,792
4,555,792
4,555,792
4,555,792
4,555,792
4,555,792
4,555,792
4,555,792
20,483,277
20,483,2774,555,7924,555,7924,555,7924,555,7924,555,7924,555,7924,555,7924,555,7924,555,7924,555,7924,555,7924,555,7928,956,2890000000000000000
       Long Term Investments 
14,755,367
14,594,345
20,343,572
20,350,768
15,849,427
21,930,172
20,840,989
21,152,410
25,361,506
27,903,189
43,425,987
41,346,134
40,992,469
29,276,895
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000029,276,89540,992,46941,346,13443,425,98727,903,18925,361,50621,152,41020,840,98921,930,17215,849,42720,350,76820,343,57214,594,34514,755,367
       Intangible Assets 
3,809,770
8,667,668
6,442,337
6,291,029
6,187,428
6,314,771
6,137,026
6,284,028
6,090,396
5,881,437
5,438,477
5,357,771
5,431,908
5,464,653
5,285,219
5,068,074
5,061,636
12,417,046
12,073,983
14,162,426
14,099,229
13,582,392
13,687,629
15,216,619
15,018,126
11,146,685
10,803,885
10,981,135
11,705,942
35,994,543
35,994,54311,705,94210,981,13510,803,88511,146,68515,018,12615,216,61913,687,62913,582,39214,099,22914,162,42612,073,98312,417,0465,061,6365,068,0745,285,2195,464,6535,431,9085,357,7715,438,4775,881,4376,090,3966,284,0286,137,0266,314,7716,187,4286,291,0296,442,3378,667,6683,809,770
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
-2
0
0
-1
0
0
0
0
0
0
0
-1
-1
1
0
1
0
1
0
0
0010101-1-10000000-100-20000000000
> Total Liabilities 
98,890,928
93,184,965
71,679,237
69,262,446
75,761,933
81,871,814
70,280,405
82,010,981
76,176,032
72,050,459
75,724,103
81,885,071
80,656,910
75,153,959
76,698,758
77,101,879
92,292,990
91,125,560
96,065,588
95,998,588
94,732,387
87,671,267
99,736,518
98,664,108
96,458,754
82,463,208
90,032,644
87,167,877
89,415,898
157,916,043
157,916,04389,415,89887,167,87790,032,64482,463,20896,458,75498,664,10899,736,51887,671,26794,732,38795,998,58896,065,58891,125,56092,292,99077,101,87976,698,75875,153,95980,656,91081,885,07175,724,10372,050,45976,176,03282,010,98170,280,40581,871,81475,761,93369,262,44671,679,23793,184,96598,890,928
   > Total Current Liabilities 
81,533,302
74,567,276
55,452,076
51,946,043
57,215,672
62,156,066
60,716,649
71,158,215
63,762,779
58,090,902
61,426,673
64,610,827
62,259,218
55,714,627
56,014,701
54,867,854
67,440,503
66,339,683
66,944,498
65,252,932
62,964,163
65,306,983
76,219,575
72,892,847
72,727,131
74,408,019
81,825,573
77,262,781
78,767,480
106,133,855
106,133,85578,767,48077,262,78181,825,57374,408,01972,727,13172,892,84776,219,57565,306,98362,964,16365,252,93266,944,49866,339,68367,440,50354,867,85456,014,70155,714,62762,259,21864,610,82761,426,67358,090,90263,762,77971,158,21560,716,64962,156,06657,215,67251,946,04355,452,07674,567,27681,533,302
       Short-term Debt 
6,000,000
6,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000006,000,0006,000,000
       Short Long Term Debt 
6,000,000
6,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,800,000
9,800,000
6,000,000
4,500,000
4,500,000
4,500,000
4,500,000
4,500,000
3,500,000
2,500,000
500,000
986,079
490,703
14,669,995
14,669,995490,703986,079500,0002,500,0003,500,0004,500,0004,500,0004,500,0004,500,0004,500,0006,000,0009,800,0009,800,000000000000000006,000,0006,000,000
       Accounts payable 
27,908,089
19,678,790
25,671,949
25,876,517
32,721,274
30,432,460
21,776,298
30,694,207
37,404,814
30,785,595
29,874,244
35,679,556
32,540,914
17,322,512
19,476,044
22,207,321
20,476,877
18,522,175
21,341,678
23,950,921
18,428,491
17,118,714
25,567,574
27,208,053
25,158,209
22,231,801
30,795,401
28,422,616
27,217,199
31,412,266
31,412,26627,217,19928,422,61630,795,40122,231,80125,158,20927,208,05325,567,57417,118,71418,428,49123,950,92121,341,67818,522,17520,476,87722,207,32119,476,04417,322,51232,540,91435,679,55629,874,24430,785,59537,404,81430,694,20721,776,29830,432,46032,721,27425,876,51725,671,94919,678,79027,908,089
       Other Current Liabilities 
47,625,213
48,888,485
23,233,526
23,018,585
19,741,499
26,445,871
32,441,788
37,103,749
21,074,967
21,401,678
6,405,167
6,077,100
6,448,128
27,822,145
29,624,946
22,974,770
27,418,876
27,118,259
32,068,557
25,924,252
29,235,629
31,324,762
37,237,821
29,026,829
30,221,383
35,524,586
7,189,600
6,828,481
6,770,212
7,425,875
7,425,8756,770,2126,828,4817,189,60035,524,58630,221,38329,026,82937,237,82131,324,76229,235,62925,924,25232,068,55727,118,25927,418,87622,974,77029,624,94627,822,1456,448,1286,077,1006,405,16721,401,67821,074,96737,103,74932,441,78826,445,87119,741,49923,018,58523,233,52648,888,48547,625,213
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
14,297,430
17,274,245
18,397,692
19,439,332
20,684,056
22,234,025
23,698,167
23,631,557
27,966,770
29,591,336
30,613,905
21,209,965
22,362,624
24,616,941
22,577,304
6,900,869
8,207,071
9,905,095
10,648,418
51,782,188
51,782,18810,648,4189,905,0958,207,0716,900,86922,577,30424,616,94122,362,62421,209,96530,613,90529,591,33627,966,77023,631,55723,698,16722,234,02520,684,05619,439,33218,397,69217,274,24514,297,4300000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
734,874
3,902,932
3,737,206
6,909,236
6,458,792
6,386,761
6,227,328
5,888,825
5,459,217
4,984,239
4,610,053
3,514,603
3,424,584
4,013,665
3,748,313
3,686,848
3,721,079
4,516,547
3,938,385
16,303,363
16,303,3633,938,3854,516,5473,721,0793,686,8483,748,3134,013,6653,424,5843,514,6034,610,0534,984,2395,459,2175,888,8256,227,3286,386,7616,458,7926,909,2363,737,2063,902,932734,8740000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
-1
305,322
303,299
301,229
299,250
297,239
295,263
305,913
303,934
301,901
299,947
255,886
255,818
255,717
255,716
253,388
253,245
253,142
253,143
259,180
259,180253,143253,142253,245253,388255,716255,717255,818255,886299,947301,901303,934305,913295,263297,239299,250301,229303,299305,322-10000000000
> Total Stockholder Equity
230,182,481
227,446,115
252,925,300
253,228,339
256,756,342
257,041,228
296,944,728
296,944,728
298,750,735
300,482,074
296,239,286
294,185,467
294,121,189
300,874,594
299,487,146
311,188,573
325,600,010
331,255,515
329,650,634
338,812,557
340,495,026
346,934,924
346,504,220
351,083,121
356,891,609
364,400,427
372,263,387
380,274,836
386,233,122
371,779,503
371,779,503386,233,122380,274,836372,263,387364,400,427356,891,609351,083,121346,504,220346,934,924340,495,026338,812,557329,650,634331,255,515325,600,010311,188,573299,487,146300,874,594294,121,189294,185,467296,239,286300,482,074298,750,735296,944,728296,944,728257,041,228256,756,342253,228,339252,925,300227,446,115230,182,481
   Common Stock
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
27,931,470
0
0
0
0
000027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,47027,931,470
   Retained Earnings 
172,704,944
170,166,548
159,579,296
159,966,082
163,153,716
163,937,633
202,281,027
202,316,164
203,066,068
204,243,628
193,786,936
193,165,601
193,401,059
209,111,679
208,059,731
214,781,388
226,538,502
232,628,156
233,105,453
241,394,996
244,565,439
252,712,399
252,966,933
258,982,900
264,927,106
274,355,594
319,528,181
327,036,483
332,958,585
329,867,741
329,867,741332,958,585327,036,483319,528,181274,355,594264,927,106258,982,900252,966,933252,712,399244,565,439241,394,996233,105,453232,628,156226,538,502214,781,388208,059,731209,111,679193,401,059193,165,601193,786,936204,243,628203,066,068202,316,164202,281,027163,937,633163,153,716159,966,082159,579,296170,166,548172,704,944
   Capital Surplus 000000000000000000000000000000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
2,626,309
2,428,339
40,370,359
40,286,612
40,626,981
40,624,344
42,184,450
43,870,877
43,205,416
43,759,195
39,706,099
38,273,614
37,973,879
39,283,664
38,948,164
43,927,933
46,582,256
46,148,107
44,065,930
44,938,309
42,418,606
40,711,544
40,026,306
38,589,239
38,453,521
36,533,852
0
0
0
0
000036,533,85238,453,52138,589,23940,026,30640,711,54442,418,60644,938,30944,065,93046,148,10746,582,25643,927,93338,948,16439,283,66437,973,87938,273,61439,706,09943,759,19543,205,41643,870,87742,184,45040,624,34440,626,98140,286,61240,370,3592,428,3392,626,309



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue361,108,562
Cost of Revenue-170,692,716
Gross Profit190,415,846190,415,846
 
Operating Income (+$)
Gross Profit190,415,846
Operating Expense-342,332,682
Operating Income18,775,880-151,916,836
 
Operating Expense (+$)
Research Development21,548,390
Selling General Administrative90,244,269
Selling And Marketing Expenses-
Operating Expense342,332,682111,792,659
 
Net Interest Income (+$)
Interest Income3,252,815
Interest Expense-308,010
Other Finance Cost-0
Net Interest Income2,944,805
 
Pretax Income (+$)
Operating Income18,775,880
Net Interest Income2,944,805
Other Non-Operating Income Expenses-
Income Before Tax (EBT)36,955,58018,775,880
EBIT - interestExpense = -308,010
27,438,290
27,746,300
Interest Expense308,010
Earnings Before Interest and Taxes (EBIT)-37,263,590
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax36,955,580
Tax Provision-8,718,534
Net Income From Continuing Ops28,237,04628,237,046
Net Income27,438,290
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--2,944,805
 

Technical Analysis of Dongwha Pharm.Co.Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dongwha Pharm.Co.Ltd. The general trend of Dongwha Pharm.Co.Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dongwha Pharm.Co.Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dongwha Pharm.Co.Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 9,150 < 9,300 < 9,300.

The bearish price targets are: 8,350 > 8,250 > 8,070.

Tweet this
Dongwha Pharm.Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dongwha Pharm.Co.Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dongwha Pharm.Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dongwha Pharm.Co.Ltd. The current macd is -295.70979644.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dongwha Pharm.Co.Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Dongwha Pharm.Co.Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Dongwha Pharm.Co.Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Dongwha Pharm.Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartDongwha Pharm.Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dongwha Pharm.Co.Ltd. The current adx is 48.83.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Dongwha Pharm.Co.Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Dongwha Pharm.Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dongwha Pharm.Co.Ltd. The current sar is 8,836.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Dongwha Pharm.Co.Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dongwha Pharm.Co.Ltd. The current rsi is 25.36. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Dongwha Pharm.Co.Ltd Daily Relative Strength Index (RSI) ChartDongwha Pharm.Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dongwha Pharm.Co.Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dongwha Pharm.Co.Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Dongwha Pharm.Co.Ltd Daily Stochastic Oscillator ChartDongwha Pharm.Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dongwha Pharm.Co.Ltd. The current cci is -111.891087.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Dongwha Pharm.Co.Ltd Daily Commodity Channel Index (CCI) ChartDongwha Pharm.Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dongwha Pharm.Co.Ltd. The current cmo is -50.49126316.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Dongwha Pharm.Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartDongwha Pharm.Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dongwha Pharm.Co.Ltd. The current willr is -88.88888889.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Dongwha Pharm.Co.Ltd Daily Williams %R ChartDongwha Pharm.Co.Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dongwha Pharm.Co.Ltd.

Dongwha Pharm.Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dongwha Pharm.Co.Ltd. The current atr is 168.39.

Dongwha Pharm.Co.Ltd Daily Average True Range (ATR) ChartDongwha Pharm.Co.Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dongwha Pharm.Co.Ltd. The current obv is 1,099,028.

Dongwha Pharm.Co.Ltd Daily On-Balance Volume (OBV) ChartDongwha Pharm.Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dongwha Pharm.Co.Ltd. The current mfi is 9.63087012.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Dongwha Pharm.Co.Ltd Daily Money Flow Index (MFI) ChartDongwha Pharm.Co.Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dongwha Pharm.Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Dongwha Pharm.Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dongwha Pharm.Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.362
Ma 20Greater thanMa 509,058.000
Ma 50Greater thanMa 1009,439.000
Ma 100Greater thanMa 2009,683.300
OpenGreater thanClose8,570.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dongwha Pharm.Co.Ltd with someone you think should read this too:
  • Are you bullish or bearish on Dongwha Pharm.Co.Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dongwha Pharm.Co.Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dongwha Pharm.Co.Ltd

I send you an email if I find something interesting about Dongwha Pharm.Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Dongwha Pharm.Co.Ltd.

Receive notifications about Dongwha Pharm.Co.Ltd in your mailbox!